2025 annual financial data
Larimar Therapeutics 2025 Net income growth
Direct answer
Net income growth was -105.54%.
Operating income was -172,497,000 USD and net income was -165,673,000 USD.
Operating cash flow was -113,201,000 USD.
Get free Larimar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -172,497,000 USD
- Net income
- -165,673,000 USD
- Operating cash flow
- -113,201,000 USD